Related Experiment Video
Updated: Aug 9, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Immunological evaluation of cefodizime: a unique molecule among cephalosporins
1INSERM U 294, Laboratoire d'Immunologie et d'Hématologie, CHU Xavier Bichat, Paris, France.
Insights
Cefodizime, an aminothiazolyl cephalosporin antibiotic, enhances immune cell functions and restores immunity in compromised hosts. This review highlights its dual role in fighting infections and modulating the immune system.
Area of Science:
- Immunology
- Pharmacology
- Microbiology
Background:
- Cefodizime is a novel aminothiazolyl cephalosporin.
- Its immunomodulatory effects require comprehensive review.
Purpose of the Study:
- To review the immunomodulatory properties of cefodizime.
- To assess its impact on immune functions in various models.
Main Methods:
- In vitro and ex vivo studies on phagocyte and lymphocyte functions.
- Evaluation in immunocompromised animal and human models.
- In vivo efficacy studies against sensitive and resistant pathogens.
Main Results:
- Cefodizime stimulates phagocyte bactericidal activity.
- It enhances lymphocyte responses, including delayed type hypersensitivity and antibody production.
- The drug restores immune functions in immunocompromised subjects and shows efficacy in infection models.
Conclusions:
- Cefodizime exhibits significant immunomodulatory effects.
- It possesses potent antimicrobial activity and beneficial immune-modulating properties.
- Cefodizime is a promising therapeutic agent for infections, with potential immune-enhancing benefits.
Abstract:
The immunomodulatory properties of cefodizime, a new aminothiazolyl cephalosporin, are reviewed. Cefodizime displays in vitro and ex vivo stimulatory effects on phagocyte bactericidal function. It also increases certain lymphocyte responses, including delayed type hypersensitivity and antibody production. In addition, it restores various immune functions in immunocompromised animals and humans. The immunomodulating activity of this drug is further supported by its in vivo efficacy in experimental models of infections using cefodizime-sensitive or -resistant pathogens. Cefodizime appears to be a promising molecule, exhibiting potent antimicrobial activity and exerting potentially beneficial effects on the immune system.
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Antimicrobial Effectiveness
Inhibitors of Gram-positive Cell Wall Synthesis

